Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Akeso

Clinical trials sponsored by Akeso, explained in plain language.

Akeso 9926 HKEX

Chinese biopharma developing innovative antibody drugs for cancer and autoimmune diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 21 Not yet recruiting 13 Not yet finished but already full! 14 Completed 10 Terminated 1

Experimental combo for tough lung cancer hits dead end

Disease control Terminated

This study tested two immunotherapy drugs, AK119 and AK112, with or without chemotherapy, in 59 people with a specific type of advanced lung cancer (EGFR-mutant non-squamous NSCLC) that had stopped responding to standard targeted pills. The goal was to see if the combination was …

Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC